Related Experiment Video
Updated: Jul 16, 2025

05:25
Author Spotlight: Comparing Alveolar and Long Bone Remodeling to Explore OTM Model Potential
Published on: July 21, 2023
1.4K
Increased STAT3 Activation in Periodontitis Drives Inflammatory Bone Loss
M Arce1,2, M Rodriguez-Peña2, J Espinoza-Arrue2
1Department of Conservative Dentistry, Faculty of Dentistry, University of Chile, Santiago, Chile.
Journal of Dental Research
|September 12, 2023
Summary
STAT3 activation increases in epithelial and T cells during periodontitis, contributing to inflammatory alveolar bone loss. Inhibiting STAT3 reduces bone destruction in experimental periodontitis models.
Area of Science:
- Immunology
- Oral Biology
- Molecular Biology
Background:
- Periodontitis is a prevalent inflammatory disease causing periodontal tissue destruction.
- Cytokines like IL-6 and IL-23 mediate tissue destruction via the STAT3 signaling pathway.
- STAT3 is crucial for IL-17A production, a key mediator in periodontitis.
Purpose of the Study:
- To characterize STAT3 activation in human gingival tissues during periodontitis.
- To investigate the role of STAT3 in periodontitis-associated alveolar bone loss.
Main Methods:
- Cross-sectional study of human gingival tissues.
- Analysis of STAT3 phosphorylation and gene expression in experimental periodontitis.
- Evaluation of alveolar bone loss in STAT3 loss-of-function mice and pharmacologic inhibition models.
Main Results:
- Increased pSTAT3-positive cells, particularly in epithelial and T cells, were observed in periodontitis tissues.
- STAT3 phosphorylation and related gene expression were elevated during experimental periodontitis.
- STAT3 inhibition, genetically or pharmacologically, significantly reduced alveolar bone loss in periodontitis models.
Conclusions:
- STAT3 activation is heightened in specific cell types during periodontitis.
- STAT3 plays a pathogenic role in inflammatory alveolar bone loss associated with periodontitis.
Related Concept Videos
The JAK-STAT Signaling Pathway
9.0K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.0K
Osteoclasts in Bone Remodeling
3.0K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Bone Remodeling
38.4K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.4K
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K

